We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+7.66%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$455B
AUM Growth
+$26.6B
Cap. Flow
-$26.7B
Cap. Flow %
-5.87%
Top 10 Hldgs %
33.25%
Holding
16,292
New
1,466
Increased
6,223
Reduced
6,687
Closed
1,652

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$645M
2
TMUS icon
T-Mobile US
TMUS
+$640M
3
T icon
AT&T
T
+$517M
4
HUM icon
Humana
HUM
+$481M
5
BSX icon
Boston Scientific
BSX
+$400M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.24B
2
AAPL icon
Apple
AAPL
+$755M
3
META icon
Meta Platforms (Facebook)
META
+$707M
4
CAT icon
Caterpillar
CAT
+$472M
5
AMD icon
Advanced Micro Devices
AMD
+$449M

Sector Composition

Rank Sector Weight
1 Healthcare 3.33%
2 Technology 3.2%
3 Financials 2.22%
4 Industrials 2.17%
5 Consumer Discretionary 2.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACLX
10826
CALL
DELISTED
Arcellx
ACLX
$126K ﹤0.01%
4,100
-20,400
-83% -$619K
IART icon
10827
PUT
Integra LifeSciences
IART
$1.43B
$126K ﹤0.01%
2,200
-20,900
-90% -$1.18M
SBIO icon
10828
ALPS Medical Breakthroughs ETF
SBIO
$215M
$126K ﹤0.01%
4,642
-22,244
-83% -$672K
GDEN
10829
CALL
DELISTED
Golden Entertainment
GDEN
$126K ﹤0.01%
2,900
-8,100
-74% -$328K
DSP icon
10830
PUT
Viant Technology
DSP
$275M
$126K ﹤0.01%
29,000
-28,200
-49% -$122K
SWTX
10831
CALL
DELISTED
SpringWorks Therapeutics
SWTX
$126K ﹤0.01%
4,900
-41,600
-89% -$1.22M
REET icon
10832
PUT
iShares Global REIT ETF
REET
$5.09B
$126K ﹤0.01%
+5,500
New +$130K
LICY
10833
CALL
DELISTED
Li-Cycle Holdings Corp.
LICY
$126K ﹤0.01%
2,800
-7,550
-73% -$333K
MMS icon
10834
PUT
Maximus
MMS
$2.89B
$126K ﹤0.01%
1,600
+800
+100% +$61.6K
VVV icon
10835
PUT
Valvoline
VVV
$4.36B
$126K ﹤0.01%
3,600
-57,300
-94% -$1.99M
HLNE icon
10836
CALL
Hamilton Lane
HLNE
$5.74B
$126K ﹤0.01%
1,700
-3,600
-68% -$266K
CDMO
10837
CALL
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$126K ﹤0.01%
6,700
-900
-12% -$14.8K
KRON
10838
DELISTED
Kronos Bio
KRON
$126K ﹤0.01%
85,988
-125,619
-59% -$241K
MFG icon
10839
PUT
Mizuho Financial
MFG
$132B
$125K ﹤0.01%
+44,500
New +$136K
OPRT icon
10840
PUT
Oportun Financial
OPRT
$355M
$125K ﹤0.01%
32,500
+20,300
+166% +$114K
CWK icon
10841
PUT
Cushman & Wakefield Ltd
CWK
$3.38B
$125K ﹤0.01%
+11,900
New +$153K
LE icon
10842
CALL
Lands' End
LE
$384M
$125K ﹤0.01%
12,900
+7,400
+135% +$62K
CGBD icon
10843
PUT
Carlyle Secured Lending
CGBD
$781M
$125K ﹤0.01%
9,200
+4,400
+92% +$64.8K
OPY icon
10844
PUT
Oppenheimer Holdings
OPY
$1.25B
$125K ﹤0.01%
3,200
+1,900
+146% +$83.5K
AFCG
10845
PUT
AFC Gamma
AFCG
$72.1M
$125K ﹤0.01%
15,048
-6,721
-31% -$68.3K
ROM icon
10846
CALL
ProShares Ultra Technology
ROM
$1.32B
$125K ﹤0.01%
3,600
+2,900
+414% +$82.8K
IEMG icon
10847
iShares Core MSCI Emerging Markets ETF
IEMG
$159B
$125K ﹤0.01%
2,565
-545,899
-100% -$26.8M
ETWO
10848
CALL
DELISTED
E2open Parent Holdings
ETWO
$125K ﹤0.01%
21,500
+14,700
+216% +$88.8K
DRLL icon
10849
PUT
Strive US Energy ETF
DRLL
$306M
$125K ﹤0.01%
4,500
+3,400
+309% +$97.7K
KBWY icon
10850
CALL
Invesco KBW Premium Yield Equity REIT ETF
KBWY
$309M
$125K ﹤0.01%
6,800
-8,500
-56% -$173K

Similar funds

Ken Griffin's Q1 2023 Portfolio in Review

As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.

Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.

  • Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
  • Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
  • Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
  • Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
  • Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
  • Ken Griffin opened 1,466 new positions and closed 1,652 in Q1 2023.
  • Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.